We are live on ! Find out more
IOVA icon

Iovance Biotherapeutics
IOVA

251 hedge funds and large institutions have $4.98B invested in Iovance Biotherapeutics in 2021 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 98 increasing their positions, 77 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $37.9M | Put options by funds: $18.9M

27% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 77

5.5% more ownership

Funds ownership: 101.41% → 106.9% (+5.5%)

7% less funds holding

Funds holding: 269 → 251 (-18)

28% less capital invested

Capital invested by funds: $6.9B → $4.98B (-$1.92B)

29% less first-time investments, than exits

New positions opened: 41 | Existing positions closed: 58

36% less funds holding in top 10

Funds holding in top 10: 11 → 7 (-4)

Holders
251
Holders Change
-18
Holders Change %
-6.69%
% of All Funds
4.41%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.12%
New
41
Increased
98
Reduced
77
Closed
58
Calls
$37.9M
Puts
$18.9M
Net Calls
+$18.9M
Net Calls Change
-$23.1M

Top Buyers

1
AIM
ARK Investment Management
Florida
+$184M
2
Deutsche Bank
Deutsche Bank
Germany
+$181M
3
CS
Credit Suisse
Switzerland
+$98.2M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$67.8M
5
Goldman Sachs
Goldman Sachs
New York
+$48.6M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$93.1M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$86.5M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$53.9M
4
FCM
Farallon Capital Management
California
-$51.8M
5
CCM
Consonance Capital Management
New York
-$38.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
51
Artal Group
Luxembourg
$12.7M – – –
Neuberger Berman Group
52
Neuberger Berman Group
New York
$12.6M +$14.2M +341,409 +598%
American Century Companies
53
American Century Companies
Missouri
$11.7M +$1M +24,141 +7%
California Public Employees Retirement System
54
California Public Employees Retirement System
California
$9.99M -$788K -19,007 -6%
ECM
55
Endurant Capital Management
California
$9.84M +$10.6M +256,428 +473%
UBS AM
56
UBS AM
Illinois
$9.81M -$24.4K -589 -0.2%
RPAM
57
Rhenman & Partners Asset Management
Sweden
$9.34M -$1.04M -25,000 -8%
WP
58
Woodline Partners
California
$8.79M +$10.6M +255,949 +1,186%
Swiss National Bank
59
Swiss National Bank
Switzerland
$7.96M +$124K +3,000 +1%
California State Teachers Retirement System (CalSTRS)
60
California State Teachers Retirement System (CalSTRS)
California
$7.82M -$42.7K -1,030 -0.4%
CLOS
61
Compagnie Lombard Odier SCmA
Switzerland
$7.66M +$10M +241,896 New
LOAMS
62
Lombard Odier Asset Management (Switzerland)
Switzerland
$7.66M +$10M +241,896 New
D.E. Shaw & Co
63
D.E. Shaw & Co
New York
$7.53M +$4.52M +108,988 +85%
PCM
64
Peregrine Capital Management
Minnesota
$7.48M -$1.37M -33,045 -12%
SEI Investments
65
SEI Investments
Pennsylvania
$7.02M -$4.02M -97,085 -30%
E
66
Ergoteles
New York
$6.31M +$3.96M +95,578 +92%
Dimensional Fund Advisors
67
Dimensional Fund Advisors
Texas
$6.04M +$2.17M +52,425 +38%
PPA
68
Parametric Portfolio Associates
Washington
$5.99M +$2.6M +62,618 +50%
BIA
69
Biondo Investment Advisors
Pennsylvania
$5.47M -$25.9K -624 -0.4%
Two Sigma Investments
70
Two Sigma Investments
New York
$5.39M -$5.67M -136,862 -45%
Balyasny Asset Management
71
Balyasny Asset Management
Illinois
$5.3M +$6.94M +167,312 New
Citigroup
72
Citigroup
New York
$5.23M +$4.85M +116,958 +242%
State Board of Administration of Florida Retirement System
73
State Board of Administration of Florida Retirement System
Florida
$5.2M -$103K -2,480 -1%
TD Asset Management
74
TD Asset Management
Ontario, Canada
$5.04M -$1.53M -36,878 -19%
SO
75
STRS Ohio
Ohio
$4.91M +$5.82M +140,353 +958%
1 2
3
4 5

IOVA Hedge Fund Activity: Q1 2021 in Review

251 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Iovance Biotherapeutics (IOVA) for Q1 2021, worth a combined $4.98B — down 28% from $6.9B a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of IOVA and 41 opened new positions — a net loss of 17 holders — while 77 trimmed existing stakes and 98 added.

The largest buyer was ARK Investment Management, adding an estimated $184M. The largest seller was T. Rowe Price Associates, cutting an estimated $93.1M.

  • 251 institutional investors held Iovance Biotherapeutics (IOVA) as of Q1 2021, down from 269 in Q4 2020.
  • Funds reported $4.98B of Iovance Biotherapeutics stock for Q1 2021, down 28% quarter-over-quarter.
  • 41 funds opened new Iovance Biotherapeutics positions in Q1 2021 and 58 closed out, a net change of -17 holders.
  • The largest Iovance Biotherapeutics buyer in Q1 2021 was ARK Investment Management, an estimated $184M added.
  • The largest Iovance Biotherapeutics seller in Q1 2021 was T. Rowe Price Associates, an estimated $93.1M sold.

Based on aggregated 13F filings for Q1 2021.